3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Plasma cell
1
Other hematologic neoplasm
1
Myeloid
1
Lymphoid
1
Gynecologic
1
Genitourinary
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Radiation Injuries
2
Brain Neoplasms
2
Wilms Tumor
1
Testicular Neoplasms
1
Sezary Syndrome
1
Recurrence
1
Primary Myelofibrosis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Pdgfra-Associated Chronic Eosinophilic Leukemia
1
Neurotoxicity Syndromes
1
Neuroblastoma
1
Myeloproliferative Disorders
1
Mycosis Fungoides
1
Multiple Myeloma
1
Memory Disorders
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma, Non-Hodgkin
1
Lymphoma, Mantle-Cell
1
Lymphoma, Large-Cell, Immunoblastic
1
Lymphoma, Large B-Cell, Diffuse
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Leukemia, Neutrophilic, Chronic
1
Leukemia, Myelomonocytic, Juvenile
1
Leukemia, Myelomonocytic, Chronic
1
Leukemia, Myeloid, Chronic-Phase
1
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
1
Leukemia, Myeloid, Acute
1
Leukemia, Myeloid, Accelerated Phase
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Interventions
Flow Cytometry
5
Therapeutics
4
Psychiatric Rehabilitation
4
Cyclophosphamide
4
Radiotherapy
3
Polymerase Chain Reaction
3
Melphalan
3
Amplified Fragment Length Polymorphism Analysis
3
sargramostim
2
liposomal amphotericin B
2
Thiotepa
2
Peripheral Blood Stem Cell Transplantation
2
Ondansetron
2
Methylprednisolone
2
Itraconazole
2
Ipilimumab
2
Immunologic Techniques
2
Filgrastim
2
Fentanyl
2
Early Intervention, Educational
2
Dexamethasone
2
Caspofungin
2
Calcium Dobesilate
2
CTLA-4 Antigen
2
Aprepitant
2
Alemtuzumab
2
thymoglobulin
1
tazemetostat
1
imetelstat
1
dostarlimab
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Hodgkin Disease
×
Lithium
×
CNS
×
Clear all
NCT00408681
2017-03-07
GVHD
Fred Hutchinson Cancer Center
Phase NA
Completed
20 enrolled
27 charts